8-K - Prelude Therapeutics Incorporated | StockGist

Current Report Details

Event Type

Financial Results

Regulation Fd

Exhibits Only

Disclosure

Mandatory

Variant

8-K

Items Reported

2.02

Results of Operations and Financial Condition. On May 6, 2025, Prelude Therapeutics Incorporated (the "Company") issued a press release announcing its financial

Financial Results

7.01

Regulation FD Disclosure. The Company has prepared investor presentation materials with information about the Company, which it intends to use as part of invest

Regulation Fd

9.01

Financial Statements and Exhibits. (d) Exhibits Exhibit Number Description 99.1 Press release issued by Prelude Therapeutics Incorporated regarding its financia

Exhibits Only

Source Document

Exhibits (3)

8-K

99.1

EX-99.1

99.2

EX-99.2